Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KELLY D SKRETTA

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner

NPI
1528381050
CMS profile
1232208
Location
NORTH KANSAS CITY, MO

General Payments · PY2021–2024

$620.64

  • Reported across 32 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$271.51

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $271.51 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Astellas Pharma US Inc $53.45 2
Lilly USA, LLC $34.91 2
DEXCOM, INC. $34.48 2
ABBVIE INC. $34.03 2
Phathom Pharmaceuticals, Inc. $27.41 1
GlaxoSmithKline, LLC. $23.23 1
Amgen Inc. $16.88 1
Exact Sciences Corporation $15.99 1
PFIZER INC. $15.95 1
Acerta Pharma LLC $15.18 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $53.80 3
PY2022 $44.34 3
PY2023 $250.99 12
PY2024 $271.51 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $19.59 03/19/2024 Food and Beverage Undisputed 01/23/2026 1108209322 CMS
ABBVIE INC. $14.44 06/03/2024 Food and Beverage Undisputed 01/23/2026 1108209324 CMS
Amgen Inc. $16.88 09/30/2024 Food and Beverage Undisputed 01/23/2026 1117686320 CMS
Astellas Pharma US Inc $32.21 09/24/2024 Food and Beverage Undisputed 01/23/2026 1139533088 CMS
Astellas Pharma US Inc $21.24 12/10/2024 Food and Beverage Undisputed 01/23/2026 1139556347 CMS
AstraZeneca Pharmaceuticals LP $15.18 10/18/2024 Food and Beverage Undisputed 01/23/2026 1104439771 CMS
Dexcom, Inc. $16.79 05/03/2024 Food and Beverage Undisputed 01/23/2026 1153371233 CMS
Dexcom, Inc. $17.69 07/30/2024 Food and Beverage Undisputed 01/23/2026 1153371235 CMS
Exact Sciences Corporation $15.99 04/24/2024 Food and Beverage Undisputed 01/23/2026 1114442372 CMS
GlaxoSmithKline, LLC. $23.23 05/08/2024 Food and Beverage Undisputed 01/23/2026 1116422715 CMS
Lilly USA, LLC $15.27 02/27/2024 Food and Beverage Undisputed 01/23/2026 1135772668 CMS
Lilly USA, LLC $19.64 04/02/2024 Food and Beverage Undisputed 01/23/2026 1135769000 CMS
PFIZER INC. $15.95 07/13/2024 Food and Beverage Undisputed 01/23/2026 1131618812 CMS
Phathom Pharmaceuticals, Inc. $27.41 02/10/2024 Food and Beverage Undisputed 01/23/2026 1151205957 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.